Vaccines, Virosome < Vaccinia virus < Vacuoles

Facettes : Author.f Mesh.f AffPays.f

List of bibliographic references

Number of relevant bibliographic references: 24.
[0-20] [0 - 20][0 - 24][20-23][20-40]

Ident.	Authors (with country if any)	Title
000745 (2004)	Tae Woo Kim [États-Unis] ; Jin Hyup Lee ; Chien-Fu Hung ; Shiwen Peng ; Richard Roden ; Mei-Cheng Wang ; Raphael Viscidi ; Ya-Chea Tsai ; Liangmei He ; Pei-Jer Chen ; David A K. Boyd ; T-C Wu	Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus.
000763 (2004)	Himani Bisht ; Anjeanette Roberts [États-Unis] ; Leatrice Vogel [États-Unis] ; Alexander Bukreyev [États-Unis] ; Peter L. Collins [États-Unis] ; Brian R. Murphy [États-Unis] ; Kanta Subbarao [États-Unis] ; Bernard Moss	Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice
000B67 (2004)	Hana Weingartl [Canada] ; Markus Czub ; Stefanie Czub ; James Neufeld ; Peter Marszal ; Jason Gren ; Greg Smith ; Shane Jones ; Roxanne Proulx ; Yvonne Deschambault ; Elsie Grudeski ; Anton Andonov ; Runtao He ; Yan Li ; John Copps ; Allen Grolla ; Daryl Dick ; Jody Berry ; Shelley Ganske ; Lisa Manning ; Jingxin Cao	Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets.
000C75 (2005)	Paul Britton [Royaume-Uni] ; Sharon Evans ; Brian Dove ; Marc Davies ; Rosa Casais ; Dave Cavanagh	Generation of a recombinant avian coronavirus infectious bronchitis virus using transient dominant selection.
000D83 (2005)	Zhiwei Chen ; Linqi Zhang ; Chuan Qin ; Lei Ba ; Christopher E. Yi ; Fengwen Zhang ; Qiang Wei ; Tian He ; Wenjie Yu ; Jian Yu ; Hong Gao ; Xinming Tu ; Agegnehu Gettie ; Michael Farzan ; Kwok-Yung Yuen ; David D. Ho	Recombinant Modified Vaccinia Virus Ankara Expressing the Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus Induces Protective Neutralizing Antibodies Primarily Targeting the Receptor Binding Region
001490 (2006)	Koji Ishii [Japon] ; Hideki Hasegawa [Japon] ; Noriyo Nagata [Japon] ; Tetsuya Mizutani [Japon] ; Shigeru Morikawa [Japon] ; Tetsuro Suzuki [Japon] ; Fumihiro Taguchi [Japon] ; Masato Tashiro [Japon] ; Toshitada Takemori [Japon] ; Tatsuo Miyamura [Japon] ; Yasuko Tsunetsugu-Yokota [Japon]	Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs
001676 (2006)	Masahiro Kitabatake [Japon] ; Shingo Inoue [Japon] ; Fumihiko Yasui [Japon] ; Shoji Yokochi [Japon] ; Masaaki Arai [Japon] ; Kouichi Morita [Japon] ; Hisatoshi Shida [Japon] ; Minoru Kidokoro [Japon] ; Fukashi Murai [Japon] ; Mai Quynh Le [Viêt Nam] ; Kyosuke Mizuno [Japon] ; Kouji Matsushima [Japon] ; Michinori Kohara [Japon]	SARS-CoV spike protein-expressing recombinant vaccinia virus efficiently induces neutralizing antibodies in rabbits pre-immunized with vaccinia virus
001727 (2006)	Koji Ishii [Japon] ; Hideki Hasegawa ; Noriyo Nagata ; Tetsuya Mizutani ; Shigeru Morikawa ; Masato Tashiro ; Tetsuro Suzuki ; Fumihiro Taguchi ; Toshitada Takemori ; Tatsuo Miyamura ; Yasuko Tsunetsugu-Yokota	Highly attenuated vaccinia virus DIs as a potential SARS vaccine.
001962 (2007)	Shuo Shen [Singapour] ; Timothy H P. Tan ; Yee-Joo Tan	Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV.
001A03 (2007)	Lei Ba ; Christopher E. Yi ; Linqi Zhang ; David D. Ho ; Zhiwei Chen	Heterologous MVA-S prime Ad5-S boost regimen induces high and persistent levels of neutralizing antibody response against SARS coronavirus
001A73 (2007)	Sen Hu [République populaire de Chine] ; Qing-Hua Wang ; Xi-Jun Wang ; Xiao-Mei Wang ; Zhi-Gao Bu	[Expression of recombinant spike protein of SARS-coronavirus in vaccinia virus and analysis of its immunogenicity].
001D52 (2008)	Kai Schulze [Allemagne] ; Caroline Staib [Allemagne] ; Hermann M. Sch Tzl [Allemagne] ; Thomas Ebensen [Allemagne] ; Volker Erfle [Allemagne] ; Carlos A. Guzman [Allemagne]	A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus
001E08 (2008)	Klara Kristin Eriksson [Suisse] ; Divine Makia ; Volker Thiel	Generation of recombinant coronaviruses using vaccinia virus as the cloning vector and stable cell lines containing coronaviral replicon RNAs.
001E32 (2009)	Xiaoxing Huang [République populaire de Chine] ; Bin Lu ; Wenbo Yu ; Qing Fang ; Li Liu ; Ke Zhuang ; Tingting Shen ; Haibo Wang ; Po Tian ; Linqi Zhang ; Zhiwei Chen	A novel replication-competent vaccinia vector MVTT is superior to MVA for inducing high levels of neutralizing antibody via mucosal vaccination.
001E48 (2009)	Kexia Yan [République populaire de Chine] ; Wenjie Tan ; Huijuan Wang ; Yue Wang ; Xiangmin Zhang ; Yan Li ; Li Ruan	SARS-CoV spike proteins expressed by the vaccinia virus Tiantan strain: secreted sq protein induces robust neutralization antibody in mice.
001F31 (2009)	Satoshi Ohno [Japon] ; Shunsuke Kohyama [Japon] ; Maiko Taneichi [Japon] ; Osamu Moriya [Japon] ; Hidenori Hayashi [Japon] ; Hiroshi Oda [Japon] ; Masahito Mori [Japon] ; Akiharu Kobayashi [Japon] ; Toshitaka Akatsuka [Japon] ; Tetsuya Uchida [Japon] ; Masanori Matsui [Japon]	Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice
002101 (2010)	Huan Liu [République populaire de Chine] ; Wenbo Yu ; Xian Tang ; Haibo Wang ; Wenjie Ouyang ; Jingying Zhou ; Zhiwei Chen	The route of inoculation determines the tissue tropism of modified vaccinia Tiantan expressing the spike glycoprotein of SARS-CoV in mice.
002475 (2012)	Sjoerd H E. Van Den Worm [Pays-Bas] ; Klara Kristin Eriksson ; Jessika C. Zevenhoven ; Friedemann Weber ; Roland Züst ; Thomas Kuri ; Ronald Dijkman ; Guohui Chang ; Stuart G. Siddell ; Eric J. Snijder ; Volker Thiel ; Andrew D. Davidson	Reverse genetics of SARS-related coronavirus using vaccinia virus-based recombination.
002923 (2014)	Arwen F. Altenburg [Pays-Bas] ; Joost H C M. Kreijtz [Pays-Bas] ; Rory D. De Vries [Pays-Bas] ; Fei Song [Allemagne] ; Robert Fux [Allemagne] ; Guus F. Rimmelzwaan [Pays-Bas] ; Gerd Sutter [Allemagne] ; Asisa Volz [Allemagne]	Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases.
003C05 (1993)	S. Kyuwa [États-Unis] ; S A Stohlman	Establishment of MHV-A59 S protein specific cytotoxic T lymphocyte clones.
003C24 (1993)	E. Flory [Allemagne] ; A. Stühler ; H. Wege ; S. Siddell ; H. Wege	Recombinant vaccinia viruses which express MHV-JHM proteins: protective immune response and the influence of vaccination on coronavirus-induced encephalomyelitis.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Vaccinia virus" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Vaccinia virus" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Vaccinia virus
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021